Niraparib Offers New Option in Heavily Pretreated Ovarian Cancer

Researchers conducted the QUADRA trial to examine if niraparib could improve outcomes in heavily pretreated patients with ovarian cancer.

Source: CancerNetwork - April 17, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news